Lactose (India) is currently trading at Rs. 164.75, up by 6.40 points or 4.04% from its previous closing of Rs. 158.35 on the BSE.
The scrip opened at Rs. 165.45 and has touched a high and low of Rs. 166.25 and Rs. 159.00 respectively. So far 8212 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 166.95 on 12-Jun-2017 and a 52 week low of Rs. 61.00 on 07-Feb-2017.
Last one week high and low of the scrip stood at Rs. 166.25 and Rs. 144.25 respectively. The current market cap of the company is Rs. 159.51 crore.
The promoters holding in the company stood at 31.84%, while Institutions and Non-Institutions held 0.81% and 67.36% respectively.
Lactose has entered into deed of Hypothecation with Piramal Finance for availing the credit facility in the form of rupee term loan not exceeding the sum of Rs 41 crore for meeting various requirements of the company as mentioned in the term sheet on such other terms and conditions as may be agreed between the parties.
Lactose (India) forces home one strong promise only the best is good enough for our customers and good enough to carry our name Products that leave the company's manufacturing facility in Vadodara, Gujarat, are sure to meet the exacting standards set by the company and its demanding customers.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: